Dow Up0.15% Nasdaq Up0.21%

Supernus Pharmaceuticals, Inc. (SUPN)

-NGM
8.43 0.18(2.18%) Sep 17, 4:00PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income (92,273) (46,284) 53,815  
Operating Activities, Cash Flows Provided By or Used In
Depreciation3,775  1,201  1,097  
Adjustments To Net Income24,874  1,096  (93,306)
Changes In Accounts Receivables(4,862)(675)158  
Changes In Liabilities17,607  (869)277  
Changes In Inventories(6,000)(1,152) -  
Changes In Other Operating Activities(1,070)(516)(247)
Total Cash Flow From Operating Activities (57,949) (47,199) (36,185)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(1,646)(753)(685)
Investments(9,761)(48,206)8,980  
Other Cash flows from Investing Activities(705) -  25,607  
Total Cash Flows From Investing Activities (12,112) (48,959) 33,902  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock710  100,735  29  
Net Borrowings65,656  (6,775)30,000  
Other Cash Flows from Financing Activities -   -  (1,967)
Total Cash Flows From Financing Activities 62,739   87,916   27,087  
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents (7,322) (8,242) 24,804  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.